Investors in Medical Device

Cube Labs, the venture builder in the healthcare technology space in Italy. We are venture builders enabling innovation in the healthcare technology space. We build companies from promising early-stage R&D, and provide entrepreneurial and operational support at all the stages of their life cycle to transform pioneering science into healthcare solutions.

Cur8 Capital is a trading name of IFG.VC Limited, a subsidiary of Islamicfinanceguru Limited. IFG.VC Limited is authorised and regulated by the FCA (No. 943736). Cur8 Capital provides a platform showcasing various investment opportunities, though it does not promote any specific investment to the public. The information presented is meant to demonstrate the types of investments available. Detailed campaigns are accessible to authorised investors on the Cur8 Capital platform. Investment activities are confined to the United Kingdom, and potential investors outside the UK should verify local regulations. This page does not offer financial or tax advice, as tax treatment varies per individual circumstances and may change.

Eurovestech PLC is an AIM-listed pan-European development capital fund that specializes in investing in high-technology enterprises. The firm focuses on identifying and supporting innovative companies across Europe with high growth potential, particularly in sectors such as technology and digital media. Eurovestech provides strategic development capital to help these enterprises accelerate their growth, expand their market presence, and achieve their strategic objectives. As a publicly listed company on the AIM market, Eurovestech offers investors the opportunity to participate in the growth of promising high-tech businesses through transparent and regulated investment vehicles. The firm's investment strategy emphasizes active management and value creation, aiming to maximize shareholder value while supporting the development of transformative technologies and businesses.

Rosetta Capital Limited operates as a private equity and venture capital firm specializing in direct secondary investments. The firm focuses on acquiring direct stakes in private companies from existing shareholders, providing liquidity and growth capital to support these businesses. Rosetta Capital's investment strategy involves identifying attractive opportunities in established companies with strong growth potential and sustainable business models. By leveraging its expertise in direct secondary transactions, the firm aims to generate value and foster growth within its portfolio companies. Rosetta Capital plays a crucial role in the secondary market, facilitating transactions that enable shareholders to realize value while positioning portfolio companies for continued success and expansion.

ACT Venture Partners is a venture capital firm based in Dublin, Ireland, focusing on investing in early-stage and growth-stage technology companies across Europe. The firm targets sectors such as software, internet, digital media, and healthcare technology, aiming to support innovative companies with high growth potential. Founded with a commitment to partnering with ambitious entrepreneurs, ACT Venture Partners provides both financial investment and strategic guidance to help startups scale and succeed in competitive markets. The firm's investment approach emphasizes active involvement in portfolio companies, leveraging its network and expertise to accelerate growth and maximize value creation. ACT Venture Partners seeks to identify disruptive technologies and business models that can achieve leadership positions in their respective markets. Their investment strategy includes backing promising founders and teams, supporting them through various stages of growth from seed funding to later-stage rounds.

NextGen Ventures is a venture capital firm based in the Netherlands, specializing in early-stage investments in innovative technology startups. Founded with a focus on supporting ambitious entrepreneurs, NextGen Ventures seeks to back companies with the potential to disrupt their industries and achieve substantial growth. The firm's investment strategy centers around sectors such as software, fintech, healthtech, artificial intelligence, and other emerging technologies. NextGen Ventures provides seed and early-stage funding to startups, aiming to help them scale their businesses and bring innovative solutions to market. Beyond financial support, NextGen Ventures offers strategic guidance and operational expertise to its portfolio companies. This includes assistance with business development, market expansion, and accessing additional rounds of funding. The firm also leverages its network of industry connections and partners to create opportunities for growth and collaboration. NextGen Ventures is known for its hands-on approach and commitment to partnering with visionary founders. They aim to build long-term relationships and support startups through various stages of growth, from initial concept development to scaling into successful enterprises.

Samen Slimmer is an investment firm dedicated to fostering innovation by strategically backing visionary startups and scalable businesses. They leverage expertise and resources to propel growth, emphasizing sustainable development and impactful contributions across sectors. Operating proactively, they seek promising opportunities aligned with their investment criteria and strategic objectives.

Value Creation Capital (VCC) is a prominent venture capital firm based in the Netherlands, specializing in technology-driven investments across Europe. With a strategic focus on sectors like enterprise software, IT infrastructure, cybersecurity, and digital health, VCC targets early-stage and growth-stage companies poised for substantial growth and market disruption. The firm distinguishes itself by not only providing financial capital but also offering hands-on strategic support and industry expertise to its portfolio companies. This approach is designed to accelerate their growth trajectory, expand market presence, and strengthen operational capabilities. VCC's commitment to creating long-term value through proactive investment management and fostering synergistic partnerships underscores its role as a key player in nurturing innovation and driving sustainable business development within the technology sector. For entrepreneurs and companies seeking to scale their ventures with strategic backing, VCC serves as a trusted partner known for its collaborative approach and dedication to maximizing the potential of innovative businesses.

Advent Life Sciences is a venture capital firm dedicated to investing in life sciences businesses. Focusing on innovative companies in biotechnology, pharmaceuticals, medical devices, and diagnostics, Advent Life Sciences supports the development of breakthrough technologies and therapies. By providing capital and strategic expertise, the firm helps entrepreneurs navigate the complexities of the life sciences sector, accelerating the path from research to market. Advent Life Sciences is committed to advancing healthcare solutions that improve patient outcomes and address unmet medical needs globally.

NetScientific PLC (AIM: NSCI), we are a deep tech and life sciences venture capital investment group with a diverse international portfolio of innovative companies. Based in London, United Kingdom, our focus is on identifying, investing in, and nurturing high-growth businesses both locally and globally. Our approach involves adding significant value through proactive portfolio management, guiding companies towards key value inflection points, and achieving investment returns through strategic liquidity events. We distinguish ourselves by adopting a capital-light strategy, strategically managing our balance sheet, and syndicating investments through our wholly owned VC subsidiary, EMV Capital. This lean structure allows us to effectively support a broad portfolio while maintaining flexibility and scalability. Listed on AIM, a market operated by the London Stock Exchange, we uphold our commitment to transparency and accountability in all our investment operations.

Mérieux Equity Partners is one of the most recognized and active European Investment firms in the Healthcare sector. We support the development and growth of high-potential companies from business launch to large scale deployment through capital investment and tailor-made support based on our strong sector expertise and international network. We are an agile investor with a flexible approach in terms of minority or majority stakes. Our main focus is partnering with and investing alongside management teams.

Endeavour Vision is a leading venture capital and growth equity advisory firm focusing on commercial-stage medtech and digital health companies. We support transformative healthcare technologies that provide superior clinical benefits for patients or bring significant efficiencies to health systems. Our team offers strategic and operational expertise and extensive international experience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Relievant Medsystems, Vertiflex, and Symetis, as well as several IPOs. Endeavour Vision's international investment teams are located in Geneva, Switzerland, Minneapolis, US and San Francisco, US.